A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/4709 (2006.01) A61K 9/00 (2006.01)
Patent
CA 2304135
The invention relates to drug formulations which comprise 1-cyclopropyl-7- ([S,S]- 2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-1,4-dihydro-8-methoxy-4-oxo-3- quinolonecarboxylic acid and/or pharmaceutically tolerable salts thereof and/or hydrates thereof as active compound which release the active compound they contain at a defined release rate.
L'invention concerne des formulations médicamenteuses contenant comme principe actif de l'acide 1-cyclopropyl -7-([S,S]-2,8-diazabicyclo [4.3.0]non-8-yl)-6- fluor-1,4-dihydro-8- méthoxy-4-oxo -3-quinolonecarboxylique et/ou leurs sels et/ou hydrates pharmaceutiquement tolérables, qui libèrent le principe actif contenu avec une vitesse définie.
Bosche Patrick
Kettelhoit Stefan
Laich Tobias
Siefert Hans-Martin
Stass Heino
Aktiengesellschaft Bayer
Bayer Schering Pharma Aktiengesellschaft
Fetherstonhaugh & Co.
LandOfFree
Medicament formulation with a controlled release of an... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medicament formulation with a controlled release of an..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medicament formulation with a controlled release of an... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1647296